PALISADE BIO, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PALISADE BIO, INC. stock issued during period, value, issued for services for the quarter ending 2024-12-31 was $11.00K.
- PALISADE BIO, INC. stock issued during period, value, issued for services for the quarter ending 2024-09-30 was $51.00K.
- PALISADE BIO, INC. stock issued during period, value, issued for services for the quarter ending 2024-06-30 was $73.00K, a 49.31% decline year-over-year.
- PALISADE BIO, INC. stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $144.00K.
- PALISADE BIO, INC. stock issued during period, value, issued for services for fiscal 2024 was $135.00K.
- PALISADE BIO, INC. stock issued during period, value, issued for services for fiscal 2021 was $1.18M, a 13055.56% increase from fiscal 2020.
- PALISADE BIO, INC. stock issued during period, value, issued for services for fiscal 2020 was $9.00K.
- PALISADE BIO, INC. stock issued during period, value, issued for services for fiscal 2012 was $175.04K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2024-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $135.00K 10-K · filed 2026-03-20 |
| 2024-09-30 | $51.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $73.00K 10-Q · filed 2025-08-11 | |
| 2023-06-30 | $144.00K 10-Q · filed 2024-08-12 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $1.18M 10-K · filed 2023-03-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | |
| 2021-06-30 | $1.18M 10-Q · filed 2022-08-15 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $9.00K 10-K · filed 2022-03-17 |
| 2020-06-30 | $9.00K 10-Q · filed 2021-08-23 | |
| 2012-12-31 | $175.04K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |